Haemonetics Corporation
$5.68B- Market cap
- $4.68B
- Debt
- +$1.24B
- Cash
- −$245.44M
Capital structure 79% equity / 21% debt · EV / Revenue 4.26x · EV / EBITDA 21.58x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: HAE stock price vs CCI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CCI's multiple
Needs CCI P/E.
Implied fair value · at HAE's multiple
Needs HAE P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HAE FY 2026 (ended Mar 28, 2026) · CCI FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 79% equity / 21% debt · EV / Revenue 4.26x · EV / EBITDA 21.58x
Capital structure 57% equity / 43% debt · EV / Revenue 13.25x · EV / EBITDA 26.64x
CCI carries the larger enterprise value at $56.50B against $5.68B; HAE trades on the lower EV / Revenue multiple (4.26x vs 13.25x); HAE on the lower EV / EBITDA (21.58x vs 26.64x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Haemonetics Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
CROWN CASTLE INC. · implied price per share
Bear
$24.14
Base
$35.47
Bull
$55.63
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.56x
-14.89x
Net debt / EBITDA
Leverage against operating earnings
3.80x
11.43x
Cash and equivalents
Liquid reserves on the balance sheet
$245.44M
$99.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BECTON DICKINSON & CO
HAE vs BDX
BAXTER INTERNATIONAL INC
HAE vs BAX
LivaNova PLC
HAE vs LIVN
STERIS plc
HAE vs STE
EQUINIX INC
HAE vs EQIX
DigitalBridge Group, Inc.
HAE vs DBRG
SBA COMMUNICATIONS CORP
HAE vs SBAC
Prologis, Inc.
HAE vs PLD
WEYERHAEUSER CO
HAE vs WY
COSTAR GROUP, INC.
HAE vs CSGP
$1.24B
$24.34B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.